COMMD3-BMI1 is a readthrough transcript located on chromosome 10 that appears to function as a regulatory gene involved in cellular proliferation and hematologic malignancy. In acute myeloid leukemia (AML), COMMD3-BMI1 was identified as a top transcription regulator within HOXA gene family regulatory networks, with involvement in cell growth, proliferation, and survival pathways 1. The gene has also been implicated in T-cell lymphoblastic lymphoma, where fusion transcripts involving COMMD3-BMI1 were detected and proposed to explain the overexpression of this driver gene 2. Additionally, COMMD3-BMI1 was identified as a hub gene in a competitive endogenous RNA (ceRNA) network associated with aldosterone-producing adenoma (APA), a common cause of secondary hypertension, suggesting potential involvement in endocrine tumorigenesis 3. The precise molecular mechanisms underlying COMMD3-BMI1 function remain incompletely characterized, though its consistent identification across multiple cancer genomic studies indicates its role as a potential oncogenic driver or regulatory factor in hematologic and endocrine malignancies. Further functional studies are needed to elucidate its specific biochemical mechanisms.